心血管情報システムの市場規模、シェア、成長分析、システムタイプ別、コンポーネント別、動作モード別、エンドユーザー別、用途別、地域別 - 産業予測、2024年～2031年

心血管情報システムの市場規模は、2022年に10億2,100万米ドルとなり、予測期間（2024年～2031年）のCAGRは7.8%で、2023年の11億63万米ドルへから、2031年までには20億722万米ドルに成長する見通しです。

世界の心血管情報システム（CVIS）市場は、主に心血管疾患の罹患率の上昇と、効率的な患者データ管理と分析に対する需要の高まりによって、力強い成長を遂げています。心血管系疾患は世界の死亡原因の上位にランクされているため、ヘルスケアプロバイダーは患者の心血管系の健康状態の管理と監視を改善するためにCVISを利用することが急務となっています。これらのシステムは、患者データを保存、アクセス、分析するための高度なツールで臨床医を支援し、最終的には、より正確な診断、カスタマイズされた治療計画、および患者の転帰の向上につながります。さらに、技術の進歩とヘルスケアの広範なデジタル化は、CVISソリューションの採用を加速させています。CVISと電子カルテ（EHR）や画像保存通信システム（PACS）とのシームレスな統合により、包括的なデータ交換が容易になり、ヘルスケアプロバイダー間の連携が強化され、タイムリーな意思決定が可能になります。しかし、市場開拓はハードルに直面しています。特に、CVIS技術の導入とメンテナンスに関連するコストが高く、新興国市場の医療施設にとっては法外な負担となる可能性があります。また、複雑なデータ統合プロセス、相互運用性の問題、機密性の高い患者情報を保護するための強固なデータセキュリティの必要性といった課題も生じています。ヘルスケア組織がデータ保護規制の遵守に努める中、患者のプライバシー保護が最重要課題となっています。このような課題にもかかわらず、米国のCVIS市場は次の予測期間中も持続的なCAGRを維持すると予測されており、技術革新と投資の機会が継続することを示しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 主要な成功要因
• 競合の程度
• 主要な投資機会
• 市場のエコシステム
• ケーススタディ分析
• PESTEL分析
• 技術分析

心血管情報システム市場：システムタイプ別

• 市場概要
• CVIS
• CPACS

心血管情報システム市場：コンポーネント別

• 市場概要
• ソフトウェア
• サービス
• ハードウェア

心血管情報システム市場：動作モード別

• 市場概要
• ウェブベースのCVIS
• オンサイトCVIS
• クラウドベース

心血管情報システム市場：エンドユーザー別

• 市場概要
• 病院
  • 小規模病院
  • 中規模病院
  • 大規模病院
• 診断センター

心血管情報システム市場：用途別

• 市場概要
• カテーテル検査室CVISソリューション
• 心エコー検査室CVISソリューション
• 電気生理学研究室CVISソリューション
• 核医学心臓学CVISソリューション
• 心臓胸部センターCVISソリューション
• ECG/ホルターモニタリングCVISソリューション
• ペースメーカー/ICDラボCVISソリューション
• 心不全センターCVISソリューション
• 外来診療所CVISソリューション
• その他の用途

心血管情報システム市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Philips Healthcare（Netherlands）
• McKesson Corporation（US）
• GE Healthcare（US）
• Siemens Healthcare（Germany）
• AGFA Healthcare（Belgium）
• Lumedx（US）
• Digisonics（US）
• Fujifilm Medical Systems（Japan）
• Meditech（US）
• CardioComm Solutions, Inc.（Canada）
• Medtronic plc（Ireland）
• AliveCor, Inc.（US）
• Hewlett Packard Enterprise（US）
• iRhythm Technologies, Inc.（US）
• BioTelemetry, Inc.（US）
• Qventus（US）
• Cardiovascular Systems, Inc.（US）
• Telerhythmics, LLC（US）
• Optum（US）
• TruHearing（US）
• Biofourmis（US）

Cardiovascular Information System Market size was valued at USD 1021 Million in 2022 and is poised to grow from USD 1100.63 Million in 2023 to USD 2007.22 Million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The global cardiovascular information system (CVIS) market is experiencing robust growth, primarily driven by the rising incidence of cardiovascular diseases and the increasing demand for efficient patient data management and analysis. As cardiovascular diseases rank among the leading causes of global mortality, there is an urgent necessity for healthcare providers to utilize CVIS for improved management and monitoring of patient cardiovascular health. These systems empower clinicians with advanced tools to store, access, and analyze patient data, ultimately leading to more accurate diagnoses, customized treatment plans, and enhanced patient outcomes. Furthermore, technological advancements and the broader digitization of healthcare are accelerating the adoption of CVIS solutions. The seamless integration of CVIS with electronic health records (EHRs) and picture archiving and communication systems (PACS) facilitates comprehensive data exchange, bolstering collaboration among healthcare providers and allowing for timely decision-making. However, the market's growth trajectory faces hurdles, particularly the high costs associated with the implementation and maintenance of CVIS technologies, which can be prohibitive for healthcare facilities in developing regions. Challenges also arise from complex data integration processes, interoperability issues, and the critical need for robust data security to protect sensitive patient information. As healthcare organizations strive to comply with data protection regulations, the focus on securing patient privacy will be paramount. Despite these challenges, the US CVIS market is anticipated to maintain a sustainable compound annual growth rate (CAGR) over the next forecast period, indicating ongoing opportunities for innovation and investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiovascular Information System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiovascular Information System Market Segmental Analysis

Global Cardiovascular Information System Market is segmented by System Type, Component, Mode of Operation, End User, Application, and region. Based on System Type, the market is segmented into CVIS, and CPACS Market. Based on Component, the market is segmented into Software, Services, and Hardware. Based on Mode of Operation, the market is segmented into Web-Based CVIS, Onsite CVIS, and Cloud-Based. Based on End User, the market is segmented into Hospitals, Diagnostic Center. Based on Application, the market is segmented into Catheterization Lab CVIS Solutions, Echocardiography Lab CVIS Solutions, Electrophysiology Lab CVIS Solutions, Nuclear Cardiology CVIS Solutions, Cardiothoracic Center CVIS Solutions, ECG/Holter Monitoring CVIS Solutions, Pacemaker/ICD Lab CVIS Solutions, Heart Failure Center CVIS Solutions, Outpatient Clinic CVIS Solutions, and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiovascular Information System Market

The increasing adoption of cloud-based solutions in the healthcare sector is a significant market driver for the Cardiovascular Information System (CVIS) market. These cloud-based CVIS solutions provide enhanced remote accessibility, allowing healthcare professionals to access critical patient data from anywhere, thus improving decision-making and patient care. Additionally, the scalability of cloud solutions caters to the diverse needs of healthcare facilities, especially smaller practices that may lack extensive IT infrastructure. Cost-effectiveness, coupled with automatic data backup, reduces operational risks and improves data security. As such, the flexibility and ease of implementation of cloud-based CVIS are compelling factors that propel their adoption, boosting overall market growth.

Restraints in the Cardiovascular Information System Market

A notable market restraint for the Cardiovascular Information System (CVIS) market lies in the substantial implementation and maintenance costs, which pose a significant barrier, particularly for smaller healthcare organizations with constrained financial resources. The financial obligations associated with CVIS encompass software licensing, necessary hardware infrastructure, comprehensive training for personnel, and ongoing technical support. For these organizations, the considerable investment required can hinder the timely adoption and integration of CVIS solutions, limiting their ability to enhance patient management and care in cardiovascular departments. Consequently, the economic strain associated with CVIS deployment remains a critical challenge in the broader healthcare landscape.

Market Trends of the Cardiovascular Information System Market

The Cardiovascular Information System (CVIS) market is experiencing a notable trend towards mobile and remote access solutions, driven by the increasing demand for flexibility and efficiency in cardiovascular care. Healthcare providers are increasingly utilizing mobile applications and secure online portals to access and review critical patient data on-the-go, enabling informed decision-making and consultations from remote locations. This trend, bolstered by the rise of telemedicine and remote patient monitoring, enhances care coordination and strengthens patient-provider communication. As healthcare continues to evolve, the integration of mobile technologies into CVIS is likely to become an essential component in delivering timely and efficient cardiovascular care.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Case Study Analysis
• PESTEL Analysis
• Technological Analysis

Cardiovascular Information System Market by System Type

• Market Overview
• CVIS
• CPACS

Cardiovascular Information System Market by Component

• Market Overview
• Software
• Services
• Hardware

Cardiovascular Information System Market by Mode of Operation

• Market Overview
• Web-Based CVIS
• Onsite CVIS
• Cloud-Based

Cardiovascular Information System Market by End User

• Market Overview
• Hospitals
  • Small Hospitals
  • Medium-Sized Hospitals
  • Large Hospitals
• Diagnostic Centers

Cardiovascular Information System Market by Application

• Market Overview
• Catheterization Lab CVIS Solutions
• Echocardiography Lab CVIS Solutions
• Electrophysiology Lab CVIS Solutions
• Nuclear Cardiology CVIS Solutions
• Cardiothoracic Center CVIS Solutions
• ECG/Holter Monitoring CVIS Solutions
• Pacemaker/ICD Lab CVIS Solutions
• Heart Failure Center CVIS Solutions
• Outpatient Clinic CVIS Solutions
• Other Applications

Cardiovascular Information System Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AGFA Healthcare (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumedx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digisonics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Medical Systems (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meditech (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioComm Solutions, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hewlett Packard Enterprise (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iRhythm Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTelemetry, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qventus (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Telerhythmics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TruHearing (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments